Walgreens Boots Alliance, US9314271019

Walgreens Boots Alliance stock steadies as $11.33 quote meets private-deal headlines

Published on 08/14/2026 at 07:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Walgreens Boots Alliance stock traded at $11.33, up 1.65%, as investors weighed a delayed quote and fresh private-deal headlines tied to the chain's ownership change.

Draufsicht-Flatlay auf Apothekenprodukte: Tabletten-Blister, Medizinfläschchen, Pflaster, Thermometer und Cremebehälter auf weißer Fläche
Walgreens US9314271019 präsentiert Flatlay generischer Apothekenprodukte und Arzneimittel auf weißem Studio-Hintergrund von oben fotografiert, Illustration mit AI erstellt.

Walgreens Boots Alliance (US9314271019) traded at $11.33, up 1.65%, in a delayed Yahoo Finance quote that also showed the stock at $11.33 at the close on July 23, 2026. The quote sits beside fresh coverage on the company's post-deal structure, giving the stock a clear market anchor on August 14, 2026.

Deal structure still matters

A Yahoo Finance quote page showed Walgreens Boots Alliance at $11.33 and +0.18 for the session, while related news items on the same page pointed to the ongoing ownership shift after the Sycamore transaction. The market value signal is simple: the stock is still trading with a visible cash-style reference point rather than a normal public-equity setup.

The same page also listed the security as a delayed quote in USD and placed the latest close at July 23, 2026, 9:00:00 p.m. GMT+1. That makes the $11.33 print a dated reference point for investors tracking the post-transaction price action.

Recent reporting frame

One linked news item on the quote page highlighted that recent reporting is still centered on the Sycamore acquisition and the company going private. A second item mentioned that Walgreens names retail veteran Mike Motz as CEO after the chain takes private, which shows how the ownership change continues to shape the operating story.

For investors, the key comparison is the move from a listed drugstore chain to a private-company setup with a quoted reference value of $11.33. That is the number that now frames every follow-up headline.

Product shelf

Botanic Choice acidophilus remains one of the consumer products sold through Walgreens channels, and the company still spans pharmacy, retail health, and wellness categories even as ownership changes. The product range matters because it is the most visible part of the company's consumer-facing footprint.

Closing view

Walgreens Boots Alliance stock was quoted at $11.33, with the last close on July 23, 2026. The same quote page also showed a 1.65% gain and a $0.18 move on the session.

Facts

Company: Walgreens Boots Alliance, Inc.
ISIN: US9314271019
Ticker: 0LSZ.IL
Exchange: IOB - delayed quote
Price (as of July 23, 2026, 9:00:00 p.m. GMT+1): $11.33 USD
Market cap: $11.33 billion
Sector / Industry: Health Care / Health Care Services

Disclaimer...

en | US9314271019 | WALGREENS BOOTS ALLIANCE | boerse | 69947799 | bgmi